Examining the autoimmune disease at the molecular level led researchers to a specific molecule that could be contributing to the disease progression in patients.
A new and novel outcome measure is being used to determine effectiveness of new scleroderma treatments. Learn how Michigan Medicine is leading the way.
U-M researchers are studying an overabundant signaling protein tied to UV light sensitivity in patients with lupus.
A new study from researchers at Michigan Medicine explores links between chronic joint inflammation and cognitive impairment.
New research documents how chemicals and a certain gene activate an enzyme to increase the risk and severity of RA and bone destruction.
Researchers at the University of Michigan teamed up to investigate if kidney biomarkers would allow them to track lupus progression and signs of complications.